If you own a pet rat long enough, you will probably hear it sniffle. The sound is so common that many owners assume it is normal. It is not. Sneezing, porphyrin-stained noses, and noisy breathing in rats almost always point to the same underlying problem: Mycoplasma pulmonis, a bacterium that colonizes the respiratory tract of virtually every pet rat and causes a progressive, incurable disease called murine respiratory mycoplasmosis — more commonly known as chronic respiratory disease, or CRD.

The challenge for rat owners is not whether the infection exists. It almost certainly does. The challenge is recognizing when a stable carrier has shifted into active disease, understanding why that happens, and knowing what management — not cure — actually looks like.

This article covers the pathophysiology of M. pulmonis in pet rats, why it cannot be eliminated, what antibiotic combinations are used and why drug stewardship matters, and how cage environment is not a background detail but a direct driver of flare frequency.

Why Virtually Every Pet Rat Carries Mycoplasma

Mycoplasma pulmonis is a small, pleomorphic bacterium that lacks a cell wall. That cell-wall absence matters clinically because it makes the organism resistant to antibiotics that target cell-wall synthesis, such as penicillins and cephalosporins — drugs that are mainstays for many other bacterial infections but are useless against Mycoplasma.

Transmission occurs through direct contact with infected secretions and via aerosol over short distances. Critically, M. pulmonis is also transmitted vertically — from mother to pups in utero. The American Fancy Rat and Mouse Association (AFRMA) notes that all pet rats probably carry the organism. Charles River Laboratories, which monitors infectious agents in research animal populations, confirms that while the incidence in modern laboratory colonies is low due to rigorous barrier protocols, the organism remains common in pet and wild populations of rats and mice.

This means that even a rat from a seemingly clean home breeder is likely infected. The question is never "does my rat have Mycoplasma?" but "is the disease active or dormant?"

What Mycoplasma Actually Does to the Lungs

The pathogenesis of CRD explains why it is chronic and progressive. When M. pulmonis colonizes the respiratory epithelium, it causes ciliostasis — the cilia that normally sweep mucus and debris out of the airways stop beating. Without functional cilia, the mucociliary escalator fails. Mucus and inflammatory exudate accumulate. The organism also directly damages respiratory epithelial cells and stimulates nonspecific B-cell proliferation, producing the peribronchiolar lymphoid hyperplasia that is the histological hallmark of CRD.

Over time, the accumulated inflammatory material causes permanent airway dilation — bronchiectasis. A retrospective study cited by the MSD Veterinary Manual found that rats with dyspnea of bacterial etiology lived a median of 24 months, but the lung disease was present for most of that time. Once bronchiectasis develops, it is irreversible. The airways are permanently widened, damaged, and prone to secondary infection.

The MSD Veterinary Manual describes the disease as a slowly developing, chronic obstructive process. Small lesions may not be detectable until the rat is two to six months old, and clinical signs of chronic lung disease may not appear until twelve to eighteen months of age. The disease is a marathon, not a sprint — but flares can accelerate the damage dramatically.

Co-Pathogens and Environmental Triggers

M. pulmonis is the major component of CRD, but it is not the only player. A conference presentation archived by the Joint Pathology Center described CRD as "usually considered subsequent to the combined action of Mycoplasma pulmonis and other respiratory pathogens such as Filobacterium rodentium (formerly known as CAR bacillus), viral pathogens such as Sendai virus and rat coronavirus, and/or environmental causes such as high levels of ammonia."

The University of Missouri College of Veterinary Medicine notes that adverse environmental factors — specifically high cage ammonia levels from soiled bedding — can activate subclinical infections. The VIN ExoticsCon presentation by Dan H. Johnson, DVM, DABVP, identifies three major respiratory pathogens that cause overt clinical disease in rats (M. pulmonis, Streptococcus pneumoniae, and Corynebacterium kutscheri) plus several minor pathogens that interact synergistically with Mycoplasma.

The practical takeaway: cage hygiene, ventilation, and bedding choice are not husbandry preferences. They are disease-modifying factors. A rat carrying dormant Mycoplasma in a clean, well-ventilated cage with low ammonia may remain clinically normal for most of its life. The same rat in a poorly ventilated cage with ammonia buildup from soiled bedding may develop active, progressive respiratory disease months earlier.

What a Flare Looks Like

CRD in pet rats does not present as a single acute event. It follows a pattern of quiescence and exacerbation. Early signs of a flare include:

• Sneezing that is more frequent than the rat's baseline
• Porphyrin staining — a red-brown discharge around the eyes and nose. This is not blood; it is porphyrin produced by the Harderian gland, and its presence signals stress or illness
• Audible respiratory noise — often described as "snuffling" or "rattling"
• Reduced activity and a hunched posture

As disease progresses, signs worsen to include labored breathing, weight loss, and a rough hair coat. The RatGuide.com resource on mycoplasmosis describes the disease as chronic rather than sudden, with older, immunocompromised, or genetically susceptible rats experiencing more severe signs.

The Antibiotic Reality: Management, Not Cure

The MSD Veterinary Manual states directly: "Antimicrobials can alleviate clinical signs of respiratory disease; however, they do not eliminate the infection." AFRMA concurs: "Baytril (enrofloxacin) can help with symptoms, but not completely eliminate the bacteria. There is no effective cure."

This is the framing that matters. Antibiotics for CRD in pet rats are symptom management, not treatment in the curative sense. The goal is to suppress bacterial load enough to reduce airway inflammation, break the cycle of exudate accumulation, and buy the rat time with acceptable quality of life.

First-Line Antibiotic Combinations

The MSD Veterinary Manual recommends enrofloxacin (10 mg/kg) combined with doxycycline (5–10 mg/kg), given orally twice daily for 14 days for severe clinical signs. The Rat and Mouse Club of America (RMCA) medication chart notes that better results have been achieved when enrofloxacin is used in combination with doxycycline, compared with enrofloxacin alone.

The rationale for combination therapy is that doxycycline has both antimicrobial activity against Mycoplasma and a marked immunomodulatory effect on chronic airway inflammation. The MSD Veterinary Manual specifically notes that "doxycycline is bactericidal for mycoplasma organisms and also has a marked immunomodulatory effect on the chronic airway inflammation."

Chronic Maintenance

For rats that relapse repeatedly when taken off antibiotics, the MSD Veterinary Manual recommends chronic low-dose doxycycline at 5–10 mg/kg orally every 24 hours to prevent acute relapses. The RatGuide.com treatment protocols describe maintenance schedules at reduced doses after initial 6-to-8-week courses, and note that pulse antibiotic therapy — long-term intermittent dosing — may be a consideration for rats whose chronic mycoplasmosis is controlled while on medication.

Why Antibiotic Stewardship Matters for a Single Rat

The temptation with an incurable bacterial infection is to keep the rat on continuous, rotating antibiotics indefinitely. But Mycoplasma is never eliminated, which means the antibiotic pressure is constant and the selection pressure for resistant organisms is ongoing. Additionally, prolonged antibiotic use disrupts the rat's normal gastrointestinal flora, which can cause secondary digestive problems.

Practical stewardship for pet rat CRD:

• Treat flares with defined courses, not open-ended prescriptions. A 14-to-28-day course of enrofloxacin plus doxycycline for an active flare is standard.
• Use chronic low-dose doxycycline only for rats that genuinely relapse every time antibiotics are stopped. Not every rat needs maintenance therapy.
• Do not rotate through multiple antibiotic classes in rapid succession. If a combination is working, continue it for the full course before switching.
• Reassess the environment before escalating medication. A flare triggered by high ammonia from dirty bedding should be addressed by cleaning the cage, not by adding a third antibiotic.

Nebulization and Supportive Care

For moderate to advanced disease, nebulization can provide symptomatic relief that oral antibiotics alone cannot. RatGuide.com describes nebulization protocols using sterile saline with gentamicin and albuterol, administered for 15 minutes two to three times daily for 14 days. Nebulization delivers medication directly to the airway surface, which is especially useful when thick mucus is contributing to airway obstruction.

Bronchodilators are another supportive tool. The MSD Veterinary Manual recommends theophylline (10 mg/kg orally, twice daily) or aerosolized albuterol as primary treatment for the inflammatory component of CRD. Bronchodilators do not treat the infection, but they reduce airway resistance and can make breathing measurably easier during flares.

For advanced cases where antibiotic response is poor, RatGuide.com describes adding a short course of dexamethasone to reduce severe airway inflammation, with a tapering schedule over approximately 12 days. Corticosteroids carry their own risks — especially immunosuppression in an animal with a chronic infection — and should be used only under veterinary direction for specific clinical scenarios.

What Owners Should Ask

• "Is this a Mycoplasma flare or is there a secondary infection? Should we do any diagnostics before starting antibiotics?"
• "What antibiotic combination are you recommending, and what is the planned course length?"
• "Should we add nebulization or bronchodilators, or are oral medications enough for this flare?"
• "Is chronic maintenance doxycycline appropriate for this rat, or should we treat flares as they come?"
• "Can you help me evaluate the cage setup? I want to reduce ammonia and improve ventilation."

The Longer View

Managing CRD in a pet rat is a long game. The infection was present before you acquired the rat, and it will be present for the rat's entire life. Antibiotics manage symptoms but do not change the underlying trajectory. Cage environment — cleanliness, ventilation, bedding type, cage-mate density — is a direct modifier of how often and how severely the disease flares.

A rat in a well-managed environment may have two or three mild flares over its lifespan that respond to a single antibiotic course. A rat in a poorly managed environment may progress to severe bronchiectasis and chronic respiratory compromise within the first year of life. The difference is often not the rat or the bacteria. It is the cage.

Sources

• Merck Veterinary Manual. Mice and Rats as Pets — Respiratory Disease. https://www.merckvetmanual.com/exotic-and-laboratory-animals/rodents/mice-and-rats-as-pets
• RatGuide.com. Mycoplasma / Mycoplasmosis. https://ratguide.com/health/bacteria/mycoplasma_mycoplasmosis.php
• American Fancy Rat and Mouse Association (AFRMA). Mycoplasma Pulmonis Update. https://www.afrma.org/med_mycoupdate.htm
• Rat and Mouse Club of America (RMCA). Medication Usage Chart for Rat Respiratory Illnesses. https://www.rmca.org/Articles/ratdrugs.pdf
• Charles River Laboratories. Mycoplasma pulmonis — Infectious Agent Information. https://www.criver.com/products-services/research-models-services/animal-health-surveillance/infectious-agent-information/mycoplasma-pulmonis
• University of Missouri College of Veterinary Medicine. Mycoplasma pulmonis — Diseases of Research Animals. https://cvm.missouri.edu/diseases-of-research-animals-dora/rats/mycoplasma-pulmonis
• Joint Pathology Center (JPC) Wednesday Slide Conference. Case 03, Conference 21, 2024: Murine Respiratory Mycoplasmosis. https://www.askjpc.org/wsco/wsc_showcase2.php?id=NWo2d0NOTm9jTVlNVTdoMzFtTGxkdz09
• VIN / ExoticsCon Virtual 2020. Respiratory Infections of Exotic Companion Mammals (Dan H. Johnson, DVM, DABVP). https://www.vin.com/apputil/content/defaultadv1.aspx?pId=25844&catId=150705&id=9768917
• Graham JE, Schoeb TR. Mycoplasma pulmonis in rats. J Exot Pet Med. 2011;20(4):270-276.